MHRA Class 2 Medicines Recall: Levothyroxine 50mcg tablets (Accord – UK Ltd, trading style: North Star)

MHRA Class 2 Medicines Recall: Levothyroxine 50mcg tablets (Accord – UK Ltd, trading style: North Star)

September 27, 2021

MHRA Class 2 Medicines Recall: Levothyroxine 50mcg tablets (Accord – UK Ltd, trading style: North Star)

Drug alert number: EL (21)A/23

MDR Number: MDR 404-09/21

Date issued: 27th September 2021

The Medicines and Healthcare products Regulatory Agency (MHRA) has issued a Class 2 medicines recall for Levothyroxine 50mcg tablets (Accord – UK Ltd, trading style: North Star).

Brief description of the problem

Accord-UK Ltd are recalling the below batch of Levothyroxine Tablets BP 50 micrograms as a precautionary measure due to out of specification results for tablet hardness obtained during stability testing. This issue may result in tablets that crumble or break when removed from the packaging.

Levothyroxine 50mcg tablets PL 0142/0104

Batch Number Expiry Date Pack Size First Distributed
XATA30 Jan 2023 28 09/08/2021

Active Pharmaceutical Ingredient: levothyroxine

Advice for healthcare professionals

Stop supplying the above batches immediately. Quarantine all remaining stock and return it to your supplier using your supplier’s approved process.

Full drug safety notice can be viewed here.

Contact details for further information:

For more information or medical information queries, please contact:

Accord-UK Ltd Medical Information Department on 01271 385257

For stock control queries, please contact:

Accord-UK Ltd Customer Services Team on 0800 373573



Posted in:


More Latest News >

PNA guidance for LPCs published

PSNC and the Department of Health and Social Care (DHSC) have both published guidance on pharmaceutical needs assessments (PNAs). The...